BioCentury
ARTICLE | Clinical News

Aldara imiquimod regulatory update

August 10, 2009 7:00 AM UTC

Graceway said FDA accepted an NDA for imiquimod cream 3.75% to treat actinic keratosis (AK). The PDUFA date was not disclosed. The company markets Aldara imiquimod cream 5% in the U.S. to treat AK, ex...